Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: a cross-sectional analysis using the food and drug administration adverse event reporting system (faers)

HIGHLIGHTS

• who: Samuel Yeroushalmi BS from the IncUniversity of have published the research: Examining worldwide postmarketing suicides from biologics used for psoriasis with a focus on brodalumab: A cross-sectional analysis using the Food and Drug Administration Adverse Event Reporting System (FAERS), in the Journal: (JOURNAL) of December/31,/2021
• how: To reporting bias from using FAERS data limitations of this study include the fact that the number of patients prescribed biologics is mostly the best estimates provided by pharmaceutical companies and that some of these values were not available at all despite the authors` best . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.